One-Week brain zaps aim to ease PTSD and pain in veterans

NCT ID NCT07192536

Not yet recruiting Symptom relief Sponsor: Legion Veterans Village Research Foundation Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a one-week course of brain stimulation (called iTBS) for veterans who have both PTSD and chronic pain. Thirty veterans will receive 5-6 short sessions each day for five days, with no placebo group. Researchers will track changes in PTSD symptoms, pain, mood, and daily function at several points over six weeks to see if this approach is feasible and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcranial magnetic stimulation (intermittent theta burst stimulation)
What this could lead to: If it works, this could offer a fast, non-invasive treatment option for veterans struggling with both PTSD and chronic pain, potentially reducing symptoms in just one week.
What could go wrong: This is a small, early-phase study with only 30 participants and no placebo group, so results may not be conclusive. The device is used off-label for these conditions, and benefits may not last beyond the 6-week follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN POST TRAUMATIC STRESS DISORDER (PTSD)

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Brainstim Health

Surrey, British Columbia, V3Z 1H8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.